Anumigilimab

CSL324 · CSL Behring

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anumigilimab, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) [Phase 2]